Open Access Article
Mohamed
Ettaoussi
*ab,
Basile
Pérès
ab,
Christian
Jarry
c,
Viviane
Pallage
d,
Olivier
Nosjean
e,
Jean A.
Boutin
e,
Arnaud
Gohier
f,
Clotilde
Mannoury la Cour
f,
Daniel-Henri
Caignard
f,
Philippe
Delagrange
f,
Pascal
Berthelot
ab and
Saïd
Yous
*ab
aUniv Lille Nord de France, F-59000 Lille, France. E-mail: said.yous@univ-lille2.fr; m.ettaoussi@yahoo.fr; Fax: +33 3 2096 4913; Tel: +33 3 2096 4375
bUDSL EA GRIIOT UFR Pharmacie, F-59000 Lille, France
cUniversité de Bordeaux CNRS FRE 3396, Pharmacochimie, 146 Rue Léo Saignat, 33000 Bordeaux, France
dInstitut des Neurosciences Cellulaires et Intégratives, CNRS UPR-3212, 67000 Strasbourg, France
eBiotechnologies, Pharmacologie Moléculaire et Cellulaire, Institut de Recherches Servier, 78290 Croissy-sur-Seine, France
fDépartement des Sciences Expérimentales Institut de Recherches Servier, 92150 Suresnes, France
First published on 12th September 2014
Correction for ‘Synthesis, chiral resolution, absolute configuration assignment and pharmacological evaluation of a series of melatoninergic ligands’ by Mohamed Ettaoussi et al., Med. Chem. Commun., 2014, 5, 1303–1308.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2014 |